Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C020888 |
1,2-dielaidoylphosphatidylethanolamine |
1,2-dielaidoylphosphatidylethanolamine results in decreased expression of CPA3 mRNA | decreases expression | 14668052
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CPA3 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CPA3 mRNA | affects expression | 16483693
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of CPA3 mRNA | decreases expression | 20739668
|
C014347 |
decitabine |
decitabine results in increased expression of CPA3 mRNA | increases expression | 19194470
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPA3 mRNA | affects cotreatment|increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CPA3 mRNA | increases expression | 18035473
|
D019833 |
Genistein |
Genistein results in decreased expression of CPA3 mRNA | decreases expression | 12075121
|
C010176 |
halofuginone |
halofuginone results in increased expression of CPA3 mRNA | increases expression | 17180598
|
D006581 |
Hexachlorobenzene |
Hexachlorobenzene results in increased expression of CPA3 mRNA | increases expression | 15159207
|
D012643 |
Selenium |
Selenium results in decreased expression of CPA3 mRNA | decreases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of CPA3 mRNA | increases expression | 16014739
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPA3 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CPA3 mRNA | decreases expression | 20159946 16120747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.42 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
4.42 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.04 | 16712894 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.98 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.57 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.71 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.94 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.38 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.38 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.38 | 16541309 16873071 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Hexachlorobenzene |
2.38 | 12709520 15061365 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.38 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.66 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
4.66 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.66 | 16507464 17306315 15276417 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.11 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.87 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.87 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.36 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.63 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.04 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.93 | 17110522 17681005 11677210 16105132 17333356 16919318 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 15340226 15668235 8697196 12621046 16354765 |
MESH:D003092 |
Colitis |
|
Selenium |
3.88 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.93 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
3.93 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.39 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.39 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.27 | 17906064 12540782 11461765 19923254 18071297 12153990 16081117 10774834 12705907 16485898 11743745 14550746 16177239 17562736 10915739 12594235 11287661 19370779 19739265 2444490 14725611 16393943 16781746 10663392 16109766 19164858 19085960 11529661 18713872 11834606 11739529 17522070 15968718 15619225 19416960 19420014 16227642 12958197 14986274 11421492 12392966 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.27 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.27 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.23 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.28 | 12538720 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.25 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.71 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
3.41 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
2.89 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.05 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.81 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.80 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.31 | 16598420 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.54 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.12 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.22 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 16354765 8697196 16959395 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.76 | 16870215 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
5.35 | 11874485 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
11.54 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.54 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.54 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.13 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.13 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.33 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.34 | 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.11 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.11 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.97 | 16518626 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.65 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.65 | 18980019 17468513 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.08 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.39 | 18704418 19010910 19387464 18206229 17679729 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.60 | 18055864 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
4.07 | 17180598 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.70 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
3.70 | 14739098 11172339 12175628 18458672 16489207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.70 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.65 | 19014921 12969438 16610002 12587719 19784758 16611625 19460945 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.31 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.54 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Hexachlorobenzene |
6.34 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.34 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.22 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.32 | 17077188 15276417 17306315 19931552 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.47 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
6.33 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.33 | 15318939 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.49 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.49 | 19082730 16487513 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.67 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.82 | 15107826 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.40 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.43 | 19157545 16882708 19010910 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.89 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.72 | 17141266 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.35 | 19116145 19470736 17925555 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.35 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.77 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
16.98 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
16.98 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.98 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.19 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.94 | 18514411 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.30 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.17 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.11 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.11 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
8.11 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.11 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.46 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.79 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.02 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Hexachlorobenzene |
11.42 | 9918132 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
11.42 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.90 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.90 | 11118676 11896295 11399792 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.83 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.29 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.62 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.62 | 15256057 16925846 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.62 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 16919318 15861022 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.90 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.49 | 19155313 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
3.53 | 11874485 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.71 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.71 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.10 | 16045194 16684133 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.39 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.35 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.35 | 16712894 16452187 17306315 11723127 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.06 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.84 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.14 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.05 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.54 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |